SAN DIEGO, May 28, 2002 (PRIMEZONE) -- Women First HealthCare, Inc. (Nasdaq:WFHC) today announced that Edward F. Calesa, chairman, president and CEO, will be presenting at the UBS Warburg Global Specialty Pharmaceuticals Conference on Thursday, June 6, 2002 at 9:30 AM Eastern Time (6:30 AM Pacific Time) at the Grand Hyatt Hotel in New York City. The presentation may include forward-looking information.
A webcast of Mr. Calesa's live presentation at the UBS Warburg Global Specialty Pharmaceuticals Conference will be available to all interested parties through the Company's womenfirst.com web site, Investor Relations, Interviews/Presentations area at:
http://www.irconnect.com/wfhc/pages/presentations.html (audio link and viewer controlled slides).
A webcast of Mr. Calesa's live presentation will also be available on the UBS Warburg web site, Conferences area, at:
http://webcast.mediaondemand.com/ubs/20020605 (audio portion only).
Listeners to the live webcast are encouraged to visit the above web sites at least 15 minutes prior to the beginning of the scheduled presentation to register and to download and install any necessary audio software.
Within 24 hours of Mr. Calesa's live presentation, a replay will be available on the above two web sites (formats noted) until July 6, 2002.
About Women First HealthCare, Inc.
Women First HealthCare, Inc. (Nasdaq:WFHC) is a San Diego-based specialty pharmaceutical company. Founded in 1996, its mission is to help midlife women make informed choices regarding their health care and to provide pharmaceutical products -- the Company's primary emphasis -- and lifestyle products to meet their needs. Women First HealthCare is specifically targeted to women age 40+ and their clinicians. Further information about Women First HealthCare can be found online at www.womenfirst.com, About Us and Investor Relations.